Bevacizumab and Re-irradiation vs. Bevacizumab alone for Recurrent GBM
What is the purpose of this trial?
To establish an improvement in overall survival in recurrent GBM patients receiving bevacizumab and re-irradiation compared with patients receiving bevacizumab alone.
- Radiation Therapy Oncology Group
- Last Updated:
- Study HIC#: